Shopping Cart
Remove All
Your shopping cart is currently empty
BACE1/2-IN-1 (compound 34) is an effective BACE1 and BACE2 inhibitor with IC50 values of 0.01 and 0.0053 μM, respectively. It exhibits a lower Pgp efflux ratio, improved passive permeability, and decreased metabolic stability in liver microsomes.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | BACE1/2-IN-1 (compound 34) is an effective BACE1 and BACE2 inhibitor with IC50 values of 0.01 and 0.0053 μM, respectively. It exhibits a lower Pgp efflux ratio, improved passive permeability, and decreased metabolic stability in liver microsomes. |
| In vitro | Compound 34, identified as BACE1/2-IN-1, exhibits a modest preference for BACE2 over BACE1, while maintaining a selectivity greater than 3000-fold when compared to Cathepsin D [1]. |
| In vivo | Administered subcutaneously at doses of 0-100 mg/kg in PDAPP (V717F) transgenic mice, BACE1/2-IN-1 (compound 34) significantly reduces cortical Aβ levels by 40% at 100 mg/kg and 24% at 30 mg/kg, with no significant reduction (12%NS) observed at 10 mg/kg [1]. |
| Molecular Weight | 401.57 |
| Formula | C21H31N5OS |
| Cas No. | 2671036-34-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.